How much funding has Intelligent BIO Solutions raised?

Intelligent BIO Solutions has disclosed $23.9M raised across 3 of its 4 known rounds.

Where is Intelligent BIO Solutions headquartered?

Intelligent BIO Solutions is headquartered in New York, US.

Intelligent BIO Solutions

NASDAQ: INBS

New York, US · Delaware corporation · 36 employees on LinkedIn

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that makes non-invasive drug testing products, including a fingerprint sweat analysis screening system and the SmarTest wearable sweat patch, to detect recent and longer-term drug use. Its products serve justice, rehabilitation, and workplace drug-screening markets and are sold across 35 countries while pursuing FDA clearance for U.S. entry.

Hardware Healthtech Medical Devices

Founders & leadership

Spiro SakirisinChief Financial Officer

Harry SimeonidisinChief Executive Officer

Lawrence FisherNamed on SEC filing

George MargelisNamed on SEC filing

Christopher TowersNamed on SEC filing

Board

Jason IsenbergBoard director

Steven BoyagesinBoard director

Jonathan HurdBoard director

Nicola FraserBoard director

Reported raises · per SEC filings

Form D private placements

$23.9M disclosed across 3 of 4 rounds · 2022–2025

▶$10MraisedJan 2026 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jason IsenbergDirector
Spiro SakirisExecutive Officer
Steven BoyagesDirector
Jonathan HurdDirector
Harry SimeonidisExecutive Officer
Nicola FraserDirector

Offering amount: $10M
Amount sold: $10M
Sales commissions: $900K
Placement agents: Ladenburg Thalmann & Co. Inc.
First sale: Dec 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.8MraisedAug 2025 · 7 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Steven BoyagesDirector
Jonathan HurdDirector
Spiro SakirisExecutive Officer
Harry SimeonidisExecutive Officer
Jason IsenbergDirector
Nicola FraserDirector

Offering amount: $3.8M
Amount sold: $3.8M
Sales commissions: $345.5K
Placement agents: Ladenburg Thalmann & Co. Inc.
First sale: Jul 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$10.1MraisedMar 2024 · 8 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Steven BoyagesDirector
Jason IsenbergDirector
Harry SimeonidisExecutive Officer
Christopher TowersDirector
Spiro SakirisExecutive Officer
Lawrence FisherDirector
Jonathan HurdDirector

Offering amount: $10.1M
Amount sold: $10.1M
Minimum investment: $10K
Sales commissions: $910.5K
Placement agents: Ladenburg Thalmann & Co. Inc.
First sale: Mar 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶Undisclosed amountofferedOct 2022 · 36 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Lawrence FisherDirector
George MargelisDirector
Jonathan HurdDirector
Steven BoyagesExecutive Officer, Director
Spiro SakirisExecutive Officer
Harry SimeonidisExecutive Officer
Christopher TowersDirector

First sale: Oct 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Labcorp164 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

Companies competing with Intelligent BIO Solutions for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Intelligent BIO Solutions do?: Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that makes non-invasive drug testing products, including a fingerprint sweat analysis screening system and the SmarTest wearable sweat patch, to detect recent and longer-term drug use. Its products serve justice, rehabilitation, and workplace drug-screening markets and are sold across 35 countries while pursuing FDA clearance for U.S. entry.
How much funding has Intelligent BIO Solutions raised?: Intelligent BIO Solutions has disclosed $23.9M raised across 3 of its 4 known rounds.
Where is Intelligent BIO Solutions headquartered?: Intelligent BIO Solutions is headquartered in New York, US.